Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, and pharmacokinetics/pharmacodynamics of ASC61 in adults with advanced solid tumors. The results describe saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ASC61 (ASC61)

Snippet

Sponsor: Ascletis Pharmaceuticals Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED